Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
The SELECT-SWITCH study, first head-to-head Phase 3b/4 trial, compared switching to Rinvoq versus switching to another TNF inhibitor
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
Rivaroxaban is used to treat venous thromboembolism
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The company has received five final approvals
Subscribe To Our Newsletter & Stay Updated
